Parallax Volatility Advisers’s Bausch Health BHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-14,000
| Closed | -$93.2K | – | 1601 |
|
|
2025
Q2 | $93.2K | Sell |
14,000
-13,900
| -50% | -$71.4K | ﹤0.01% | 1397 |
|
|
2025
Q1 | $181K | Sell |
27,900
-426,200
| -94% | -$3.06M | ﹤0.01% | 1329 |
|
|
2024
Q4 | $3.66M | Buy |
454,100
+42,500
| +10% | +$350K | 0.01% | 941 |
|
|
2024
Q3 | $3.36M | Buy |
411,600
+178,700
| +77% | +$1.18M | 0.01% | 954 |
|
|
2024
Q2 | $1.62M | Sell |
232,900
-68,300
| -23% | -$517K | ﹤0.01% | 1109 |
|
|
2024
Q1 | $3.2M | Buy |
301,200
+222,800
| +284% | +$1.95M | 0.01% | 874 |
|
|
2023
Q4 | $629K | Sell |
78,400
-918,700
| -92% | -$6.69M | ﹤0.01% | 1543 |
|
|
2023
Q3 | $8.2M | Buy |
997,100
+884,800
| +788% | +$7.63M | 0.02% | 593 |
|
|
2023
Q2 | $898K | Sell |
112,300
-1,019,600
| -90% | -$7.52M | ﹤0.01% | 1442 |
|
|
2023
Q1 | $9.17M | Sell |
1,131,900
-465,300
| -29% | -$3.74M | 0.02% | 618 |
|
|
2022
Q4 | $10M | Buy |
1,597,200
+275,900
| +21% | +$1.93M | 0.02% | 771 |
|
|
2022
Q3 | $9.11M | Sell |
1,321,300
-1,086,400
| -45% | -$7.55M | 0.01% | 795 |
|
|
2022
Q2 | $20.1M | Sell |
2,407,700
-1,343,800
| -36% | -$18.8M | 0.02% | 485 |
|
|
2022
Q1 | $85.7M | Buy |
+3,751,500
| New | +$91.7M | 0.04% | 156 |
|
|
2020
Q4 | – | Sell |
-656,200
| Closed | -$10.2M | – | 2434 |
|
|
2020
Q3 | $10.2M | Sell |
656,200
-81,900
| -11% | -$1.41M | 0.01% | 991 |
|
|
2020
Q2 | $13.5M | Buy |
738,100
+366,300
| +99% | +$6.45M | 0.02% | 650 |
|
|
2020
Q1 | $5.76M | Sell |
371,800
-204,000
| -35% | -$4.92M | 0.01% | 820 |
|
|
2019
Q4 | $17.2M | Buy |
575,800
+328,400
| +133% | +$8.54M | 0.02% | 467 |
|
|
2019
Q3 | $5.41M | Buy |
247,400
+157,400
| +175% | +$3.6M | 0.01% | 789 |
|
|
2019
Q2 | $2.27M | Sell |
90,000
-188,800
| -68% | -$4.48M | ﹤0.01% | 1007 |
|
|
2019
Q1 | $6.89M | Sell |
278,800
-2,351,200
| -89% | -$56.2M | 0.01% | 590 |
|
|
2018
Q4 | $48.6M | Buy |
2,630,000
+671,300
| +34% | +$16M | 0.06% | 195 |
|
|
2018
Q3 | $50.3M | Buy |
1,958,700
+588,700
| +43% | +$13.5M | 0.06% | 133 |
|
|
2018
Q2 | $31.8M | Buy |
1,370,000
+250,600
| +22% | +$5.18M | 0.05% | 189 |
|
|
2018
Q1 | $17.8M | Sell |
1,119,400
-730,400
| -39% | -$13.6M | 0.02% | 265 |
|
|
2017
Q4 | $38.4M | Buy |
1,849,800
+1,749,800
| +1,750% | +$27.7M | 0.05% | 170 |
|
|
2017
Q3 | $1.43M | Buy |
+100,000
| New | +$1.51M | ﹤0.01% | 944 |
|
|
2017
Q2 | – | Sell |
-15,000
| Closed | -$165K | – | 2294 |
|
|
2017
Q1 | $165K | Sell |
15,000
-18,600
| -55% | -$256K | ﹤0.01% | 2031 |
|
|
2016
Q4 | $488K | Sell |
33,600
-206,400
| -86% | -$3.79M | ﹤0.01% | 1518 |
|
|
2016
Q3 | $5.89M | Sell |
240,000
-200,000
| -45% | -$5.18M | 0.01% | 618 |
|
|
2016
Q2 | $8.86M | Buy |
440,000
+293,500
| +200% | +$8.31M | 0.02% | 455 |
|
|
2016
Q1 | $3.85M | Buy |
146,500
+74,000
| +102% | +$5.47M | 0.01% | 660 |
|
|
2015
Q4 | $7.37M | Buy |
72,500
+51,100
| +239% | +$5.74M | 0.02% | 540 |
|
|
2015
Q3 | $3.82M | Buy |
+21,400
| New | +$4.99M | 0.01% | 764 |
|
Other funds holding BHC
PC
GAM
MP
KKRC
Parallax Volatility Advisers's BHC Position: Q2 2025 in Review
Parallax Volatility Advisers sold out of Bausch Health (BHC) in Q2 2025, closing a stake of 28,018 shares — an estimated $144K sold.
Parallax Volatility Advisers first reported a position in BHC in Q4 2015 and held it in 21 quarters. The position peaked at $56.3M in Q1 2022. 212 funds tracked by Wall St. Rank hold BHC as of Q2 2025.
- Parallax Volatility Advisers reported no remaining Bausch Health position as of Q2 2025 after selling out during the quarter.
- Parallax Volatility Advisers sold 28,018 Bausch Health shares in Q2 2025, an estimated $144K.
- Parallax Volatility Advisers first reported a position in Bausch Health in Q4 2015 and held it in 21 quarters.
- Parallax Volatility Advisers's Bausch Health position peaked at $56.3M in Q1 2022.
- 212 funds tracked by Wall St. Rank held Bausch Health as of Q2 2025.
Based on Parallax Volatility Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.